美国商业保险人群中原发性甲状旁腺功能亢进症治疗不足:尽管手术指征扩大,甲状旁腺切除术使用率仍下降
基于美国Optum商业保险数据库的回顾性队列研究,纳入2004至2016年首次诊断原发性甲状旁腺功能亢进症的≥35岁患者26,522例。仅38.1%接受甲状旁腺切除术,且有手术指征者中也仅38.9%手术。高龄和合并症与手术几率降低独立相关。
要点
- 原发性甲状旁腺功能亢进症患者中多数未接受甲状旁腺切除术治疗。
- 有手术指征者中仅38.9%接受手术,指征对手术决策影响有限。
- 甲状旁腺切除术率随时间显著下降,从54.4%降至32.4%。
核心结论
- 美国商业保险的原发性甲状旁腺功能亢进症患者多数未接受甲状旁腺切除术,且有手术指征者手术几率仅适度增加,指南与临床实践存在差距。
研究设计与样本
- 回顾性队列研究,使用美国Optum去标识化Clinformatics Data Mart数据库,纳入2004至2016年首次诊断原发性甲状旁腺功能亢进症的≥35岁患者26,522例。
主要发现
- 26,522例患者中10,101例(38.1%)接受甲状旁腺切除术。
- 14,896例有手术指征的患者中5,791例(38.9%)接受甲状旁腺切除术。
- 多因素分析显示年龄75-84岁相比35-49岁OR为0.50(95%CI 0.45-0.55),≥85岁OR为0.21(95%CI 0.17-0.26)。
- Charlson合并症指数≥2相比0的OR为0.62(95%CI 0.58-0.66)。
临床怎么用
- 普通外科医生应关注原发性甲状旁腺功能亢进症患者的手术指征评估,尤其对高龄和合并症较多者避免治疗不足。
- 临床实践中需识别并解决阻碍甲状旁腺切除术实施的障碍,缩小指南推荐与临床实践之间的差距。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Primary hyperparathyroidism is associated with substantial morbidity, including osteoporosis, nephrolithiasis, and chronic kidney disease. Parathyroidectomy can prevent these sequelae but is poorly utilized in many practice settings. METHODS: We performed a retrospective cohort study using the national Optum de-identified Clinformatics Data Mart Database. We identified patients aged ≥35 with a first observed primary hyperparathyroidism diagnosis from 2004 to 2016. Multivariable logistic regression was used to determine patient/provider characteristics associated with parathyroidectomy. RESULTS: Of 26,522 patients with primary hyperparathyroidism, 10,101 (38.1%) underwent parathyroidectomy. Of the 14,896 patients with any operative indication, 5,791 (38.9%) underwent parathyroidectomy. Over time, there was a decreasing trend in the rate of parathyroidectomy overall (2004: 54.4% to 2016: 32.4%, P < .001) and among groups with and without an operative indication. On multivariable analysis, increasing age and comorbidities were strongly, inversely associated with parathyroidectomy (age 75-84, odds ratio 0.50 [95% confidence interval 0.45-0.55]; age ≥85, odds ratio 0.21 [95% confidence interval 0.17-0.26] vs age 35-49; Charlson Comorbidity Index ≥2 vs 0 odds ratio 0.62 [95% confidence interval 0.58-0.66]). CONCLUSION: The majority of US privately insured patients with primary hyperparathyroidism are not treated with parathyroidectomy. Having an operative indication only modestly increases the likelihood of parathyroidectomy. Further research is needed to address barriers to treatment and the gap between guidelines and clinical care in primary hyperparathyroidism.
引用
- Seib CD, Meng T, Suh I, et al. Undertreatment of primary hyperparathyroidism in a privately insured US population: Decreasing utilization of parathyroidectomy despite expanding surgical guidelines. Surgery. 2020. PMID: 32654861. doi:10.1016/j.surg.2020.04.066
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。